IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-02-06 (esculap.com)
Eating disorders may result from different brain structure
Esculap.com is the largest portal in Poland for doctors. You will find the latest information from the country, from abroad, from the world of science, interesting medical publications and others.
Read more
2025-01-23 (pharmiweb.com)
Galenica reports strong sales growth once again -
Galenica AG / Key word(s): Development of Sales23-Jan-2025 / 06:45 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Press releaseAd hoc announcement pursuant to Art. 53 LRGalenica Group sales once again performed very positively in...
Read more
2025-01-07 (ebn.co.kr)
Geoyoung, Korea's No. 1 Oral Contraceptive Exclusive Distribution Agreement < General Business < Pharmaceutical/Bio < Distribution < Text of Article -
Geoyoung has secured exclusive sales and marketing rights for Korea's No. 1 selling oral contraceptive. As a result, Geoyoung is expected to further strengthen its position in the over-the-counter (OTC) market. Geoyoung
Read more
2024-10-11 (tienphong.vn)
Bao Thanh cough lozenges and the journey to affirm the number 1 position in Vietnam
According to the latest report of IQVIA - a leading reputable market research unit in the field of Pharmaceuticals, Bao Thanh cough lozenges continue to maintain its position as the number 1 brand in terms of output and sales in the industry. herbal cough lozenges in Vietnam.
Read more
2024-09-11 (farmacja.pl)
What was the result of the holiday in pharmacies?
August was the last month of this year's holidays. IQVIA has already prepared its summary in pharmacies. What does it mean? - Holidays […]
Read more
2024-08-07 (frontiersin.org)
Women have a higher risk of hospital admission associated with hyponatremia than men while using diuretics
Background Hyponatremia is a common electrolyte disturbance and known adverse drug reaction of diuretics. Women tend to be more susceptible for diabetic assoc...
Read more
2024-07-12 (newsdirectory3.com)
Altering Perceptions of Weight problems: From Laziness to Illness
“Fats individuals are sort and lazy.” Everybody thought this fashion. [SBS 방송 캡쳐] [헤럴드경제=손인규 기자] “Is weight problems as a result of lack of self-management or laziness?” Mr. A (33), an workplace employee, mentioned he weighed greater than 100 kg when he was a university pupil.
Read more
2024-05-07 (pharmnews.com)
Tium Bio, ‘Merigolix (TU2670)’ succeeds in European phase 2a clinical trial for endometriosis
Tium Bio (KOSDAQ: 321550) announced on the 7th the topline results of Merigolix's endometriosis European clinical trial phase 2a. Topline data received from IQVIA, a contract research organization (CRO), showed that Mary As a result of the evaluation of 'reduction in dysmenorrhea', the primary endpoint of Golix's endometriosis European clinical trial phase 2a, statistical significance was achieved compared to placebo at all doses (120mg/240mg/320mg). (120mg group p=0.044, 240mg group p=0.001, 320mg group p
Read more
2024-04-09 (thepharmaletter.com)
PBM rebate schemes to suppress biosimilar Humira cost US patients $6 billion
PBM rebate schemes to suppress biosimilar Humira cost US patients $6 billion
Read more
2024-01-22 (wiadomoscikosmetyczne.pl)
Anna Pielak from Empik to DOZ
Anna Pielak moved from the Empik Group to DOZ, where she took up the position of director of the dermo and OTC products division.
Read more
2024-01-08 (pharmavoice.com)
Regulatory twists and turns are coming for biopharma in 2024
New FDA requirements and the IRA will create complexity in the coming year. Here’s how the industry can navigate the changes.
Read more
2023-11-30 (wiadomoscikosmetyczne.pl)
IQVIA: The importance of e-pharmacies in the pharmaceutical market is growing
Sales in e-pharmacies increased by over 22% in October. y/y. The stationary pharmacy market also recorded an increase in value - by almost 14%. Thus, October overtook the result from March, which was usually a record month of the year - note IQVIA Poland experts.
Read more